Clinical Trial

Efficacy and Safety of Transcranial dIrect Current stiMulation in Multiple System Atrophy-Cerebellar Variant

Study acronym: STIM-MSA
Recruiting
View on ClinicalTrials.gov →
Summary
This is a double-blind, randomized, sham-controlled clinical trial that aim to verify the safety and the efficacy of anodal transcranial direct current stimulation (tDCS) cerebellar symptoms in Multiple System Atrophy type C (MSA).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-02-06; most recent amendment 2026-04-28.
Trial Details
NCT Number NCT06821256
Lead Sponsor University of Salerno
Conditions Multiple System Atrophy - Cerebellar Subtype (MSA-C)
Enrollment 30 participants
Start Date 2023-07-03
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-29